William Pao - Feb 25, 2025 Form 4 Insider Report for Immunocore Holdings plc (IMCR)

Role
Director
Signature
/s/ Lily Hepworth, Attorney-in-Fact
Stock symbol
IMCR
Transactions as of
Feb 25, 2025
Transactions value $
$0
Form type
4
Date filed
2/27/2025, 04:31 PM
Previous filing
Apr 3, 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IMCR Share Option (Right to Buy) Award $0 +24.4K $0.00 24.4K Feb 25, 2025 Ordinary Shares 24.4K $29.21 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option vests in equal monthly installments over a three-year period measured from one month following February 25, 2025, subject to the Reporting Person's continuous service through each such vesting date.